TRCT
BSPM

Tower Research Capital (TRC)’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Tower Research Capital (TRC)’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-749
Closed -$1K – 5511
2016
Q1 		$1K Buy
+749
New +$1.7K ﹤0.01% 3972
2015
Q2 		– Sell
-29
Closed – – 5549
2015
Q1 		$0 Buy
+29
New +$233 ﹤0.01% 5392
2014
Q4 		– Sell
-458
Closed -$5K – 5286
2014
Q3 		$5K Buy
458
+100
+28% +$1.11K ﹤0.01% 3364
2014
Q2 		$4K Sell
358
-1,817
-84% -$20.1K ﹤0.01% 3117
2014
Q1 		$31K Buy
2,175
+1,322
+155% +$21K ﹤0.01% 1484
2013
Q4 		$12K Buy
+853
New +$9.22K ﹤0.01% 2873

Other funds holding BSPM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Tower Research Capital (TRC)'s BSPM Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q2 2016, closing a stake of 749 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in BSPM in Q4 2013 and held it in 6 quarters. The position peaked at $31K in Q1 2014. 8 funds tracked by Wall St. Rank hold BSPM as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining Biostar Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 749 Biostar Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Biostar Pharmaceuticals, Inc. in Q4 2013 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Biostar Pharmaceuticals, Inc. position peaked at $31K in Q1 2014.
  • 8 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.